HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Svein I Helle Selected Research

Aplastic Anemia (Anemia, Hypoplastic)

3/2018Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Svein I Helle Research Topics

Disease

4Prostatic Neoplasms (Prostate Cancer)
12/2019 - 06/2014
3Neoplasm Metastasis (Metastasis)
03/2018 - 06/2014
2Neoplasms (Cancer)
12/2019 - 03/2018
2Neutropenia
03/2018 - 11/2014
2Thrombocytopenia (Thrombopenia)
03/2018 - 11/2014
1Margins of Excision
12/2019
1Aplastic Anemia (Anemia, Hypoplastic)
03/2018
1Anemia
03/2018
1Bone Neoplasms (Bone Cancer)
03/2018
1Bone Fractures (Bone Fracture)
06/2014
1Spinal Cord Compression
06/2014
1Pain (Aches)
06/2014

Drug/Important Bio-Agent (IBA)

3Radium-223IBA
03/2018 - 06/2014
2Docetaxel (Taxotere)FDA Link
11/2014 - 06/2014
1Radium-233IBA
06/2014

Therapy/Procedure

3Castration
03/2018 - 06/2014
2Radiotherapy
12/2019 - 06/2014
1Palliative Care (Palliative Therapy)
12/2019
1Salvage Therapy
12/2019
1Prostatectomy (Retropubic Prostatectomy)
12/2019
1Injections
11/2014